These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38867417)
1. Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease. Berron D; Olsson E; Andersson F; Janelidze S; Tideman P; Düzel E; Palmqvist S; Stomrud E; Hansson O Alzheimers Dement; 2024 Jul; 20(7):4775-4791. PubMed ID: 38867417 [TBL] [Abstract][Full Text] [Related]
2. Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease. Nicosia J; Aschenbrenner AJ; Balota DA; Sliwinski MJ; Tahan M; Adams S; Stout SS; Wilks H; Gordon BA; Benzinger TLS; Fagan AM; Xiong C; Bateman RJ; Morris JC; Hassenstab J J Int Neuropsychol Soc; 2023 Jun; 29(5):459-471. PubMed ID: 36062528 [TBL] [Abstract][Full Text] [Related]
3. Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum. Vanderlip CR; Stark CEL; Alzheimers Dement; 2024 Oct; 20(10):6881-6895. PubMed ID: 39239892 [TBL] [Abstract][Full Text] [Related]
4. Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly. Niimi Y; Janelidze S; Sato K; Tomita N; Tsukamoto T; Kato T; Yoshiyama K; Kowa H; Iwata A; Ihara R; Suzuki K; Kasuga K; Ikeuchi T; Ishii K; Ito K; Nakamura A; Senda M; Day TA; Burnham SC; Iaccarino L; Pontecorvo MJ; Hansson O; Iwatsubo T Alzheimers Res Ther; 2024 May; 16(1):115. PubMed ID: 38778353 [TBL] [Abstract][Full Text] [Related]
5. Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures. Palmqvist S; Tideman P; Cullen N; Zetterberg H; Blennow K; ; Dage JL; Stomrud E; Janelidze S; Mattsson-Carlgren N; Hansson O Nat Med; 2021 Jun; 27(6):1034-1042. PubMed ID: 34031605 [TBL] [Abstract][Full Text] [Related]
6. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900 [TBL] [Abstract][Full Text] [Related]
7. A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices. Berron D; Glanz W; Clark L; Basche K; Grande X; Güsten J; Billette OV; Hempen I; Naveed MH; Diersch N; Butryn M; Spottke A; Buerger K; Perneczky R; Schneider A; Teipel S; Wiltfang J; Johnson S; Wagner M; Jessen F; Düzel E NPJ Digit Med; 2024 Mar; 7(1):79. PubMed ID: 38532080 [TBL] [Abstract][Full Text] [Related]
8. Continuous Associations between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer's Disease. Boots EA; Frank RD; Fan WZ; Christianson TJ; Kremers WK; Stricker JL; Machulda MM; Fields JA; Hassenstab J; Graff-Radford J; Vemuri P; Jack CR; Knopman DS; Petersen RC; Stricker NH J Prev Alzheimers Dis; 2024; 11(5):1467-1479. PubMed ID: 39350394 [TBL] [Abstract][Full Text] [Related]
9. Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease. Janelidze S; Berron D; Smith R; Strandberg O; Proctor NK; Dage JL; Stomrud E; Palmqvist S; Mattsson-Carlgren N; Hansson O JAMA Neurol; 2021 Feb; 78(2):149-156. PubMed ID: 33165506 [TBL] [Abstract][Full Text] [Related]
16. Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study. Zhang Y; Ferreira PCL; Jacobsen E; Bellaver B; Pascoal TA; Snitz BE; Chang CH; Villemagne VL; Ganguli M; Karikari TK Alzheimers Dement; 2024 Jun; 20(6):4199-4211. PubMed ID: 38753951 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of Digital Memory Assessments in an Unsupervised and Remote Study Setting. Berron D; Ziegler G; Vieweg P; Billette O; Güsten J; Grande X; Heneka MT; Schneider A; Teipel S; Jessen F; Wagner M; Düzel E Front Digit Health; 2022; 4():892997. PubMed ID: 35721797 [TBL] [Abstract][Full Text] [Related]
18. Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease. Howe MD; Britton KJ; Joyce HE; Menard W; Emrani S; Kunicki ZJ; Faust MA; Dawson BC; Riddle MC; Huey ED; Janelidze S; Hansson O; Salloway SP Alzheimers Res Ther; 2024 Jul; 16(1):154. PubMed ID: 38971815 [TBL] [Abstract][Full Text] [Related]
19. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. Palmqvist S; Janelidze S; Quiroz YT; Zetterberg H; Lopera F; Stomrud E; Su Y; Chen Y; Serrano GE; Leuzy A; Mattsson-Carlgren N; Strandberg O; Smith R; Villegas A; Sepulveda-Falla D; Chai X; Proctor NK; Beach TG; Blennow K; Dage JL; Reiman EM; Hansson O JAMA; 2020 Aug; 324(8):772-781. PubMed ID: 32722745 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline. Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]